CBMX Combimatrix Corp. (MM)

CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three and six months ended June 30, 2016 after market close on Wednesday, August 3, 2016.  CombiMatrix management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss those results and answer questions.

Live Call:	U.S.	(866) 634-2258
	International:	(330) 863-3454
Live Webcast:	http://edge.media-server.com/m/p/8dc72bap
	The webcast replay will be archived for 30 days
Replay:	U.S.	(855) 859-2056
	International:	(404) 537-3406
	Passcode:	53433797
	The telephone replay will be available for seven days

About CombiMatrix Corporation

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic diagnostics and screening, miscarriage analysis, prenatal and pediatric diagnostics, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making. Additional information about CombiMatrix is available at www.combimatrix.com or by calling (800) 710-0624.

Company Contact: Mark McDonough President & CEO, CombiMatrix Corporation (949) 753-0624		Investor Contact:LHA Jody Cain(310) 691-7100jcain@lhai.com